ICD-10-CM Billable Code

T46.6X5

Adverse effect of antihyperlipidemic and antiarteriosclerotic drugs

Clinical Classification Guidelines

Medical Intelligence & Overview

ICD-10 code T46.6X5 refers to adverse effects caused by medications used to manage high cholesterol and prevent arteries from hardening. These drugs play a crucial role in reducing cardiovascular risk but can sometimes lead to unwanted side effects. Recognizing these adverse effects helps in timely management and ensuring safe medication use.

Causes & Symptoms

Clinical Causes: Use of antihyperlipidemic medications such as statins, fibrates, or bile acid sequestrants Incorrect dosage or prolonged use of the drugs Drug interactions with other medications Patient-specific factors like underlying health conditions or genetic predispositions Sensitivity or allergy to certain medication components

Key Symptoms: Muscle pain, weakness, or cramps Liver function abnormalities, such as jaundice or elevated liver enzymes Digestive disturbances including nausea, diarrhea, or constipation Rash or allergic skin reactions Fatigue or general malaise Rarely, cognitive disturbances like memory issues

Diagnostic & Treatment

Diagnosis Path: Diagnosing adverse drug reactions often involves a detailed patient history, focusing on medication use and onset of symptoms. Blood tests may reveal abnormal liver enzyme levels or muscle enzyme elevations. Discontinuing the suspected medication and observing symptom resolution can help confirm the diagnosis. In some cases, imaging or additional tests might be necessary to rule out other conditions.

Treatment Protocols: Management includes stopping or adjusting the offending medication under healthcare professional guidance. Supportive care to alleviate symptoms may include medications for muscle pain or liver support. Regular monitoring of liver function and muscle enzymes is essential during treatment adjustments. Alternative therapies or different medication classes might be considered based on individual risk factors and response.

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is T46.6X5 a billable ICD-10 code?
Yes, T46.6X5 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report T46.6X5?
Clinical documentation must specify the nature of Adverse effect of antihyperlipidemic and antiarteriosclerotic drugs and any associated comorbidities for accurate reporting.

Cite this Clinical Reference